Sagimet Biosciences (SGMT) Institutional Ownership → Did Intel Just Dethrone Nvidia? (From Chaikin Analytics) (Ad) Free SGMT Stock Alerts $4.38 +0.14 (+3.30%) (As of 05/14/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Sagimet Biosciences (NASDAQ:SGMT)CurrentInstitutional OwnershipPercentage87.86%Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$49.25MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.59M Get SGMT Insider Trade Alerts Want to know when executives and insiders are buying or selling Sagimet Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SGMT Institutional Buying and Selling by Quarter Ad Banyan Hill PublishingLook Who Fired the World’s Richest ManThis company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here. Sagimet Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2024 Platinum Investment Management Ltd.90,633$491K0.0%-18.9%0.284% 5/14/2024 American International Group Inc.11,372$62K0.0%+312.0%0.036% 5/13/2024 O Shaughnessy Asset Management LLC13,344$72K0.0%N/A0.042% 5/10/2024 Acadian Asset Management LLC34,929$188K0.0%N/A0.109% 5/10/2024 Vanguard Group Inc.1,139,407$6.18M0.0%+364.9%3.570% 2/14/2024 Platinum Investment Management Ltd.111,752$606K0.0%-70.9%0.523% 2/5/2024 Victory Capital Management Inc.56,570$307K0.0%+215.0%0.265% 1/31/2024Federated Hermes Inc.97,276$527K0.0%+24.7%0.455% 11/15/2023RTW Investments LP400,277$3.52M0.1%N/A1.875% 11/15/2023Rock Springs Capital Management LP738,355$6.50M0.2%N/A3.458% 11/14/2023Dumac Inc.204,123$1.80M4.8%N/A0.956% 11/13/2023CHI Advisors LLC348,842$3.07M0.9%N/A1.634% 11/13/2023Federated Hermes Inc.78,000$686K0.0%N/A0.365% 11/13/2023Silverarc Capital Management LLC100,000$880K0.3%N/A0.468% 11/13/2023 FMR LLC2,672,355$23.52M0.0%N/A12.517% 11/7/2023 New York State Common Retirement Fund6,357$56K0.0%N/A0.030% 11/6/2023 Victory Capital Management Inc.17,960$158K0.0%N/A0.084% 11/3/2023 Platinum Investment Management Ltd.383,913$3.38M0.1%N/A1.798% 10/31/2023 Teacher Retirement System of Texas25,000$220K0.0%N/A0.117% (Data available from 1/1/2016 forward) SGMT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SGMT shares? During the previous two years, 15 institutional investors and hedge funds held shares of Sagimet Biosciences. The most heavily invested institutionals were FMR LLC ($23.52M), Rock Springs Capital Management LP ($6.50M), Vanguard Group Inc. ($6.18M), RTW Investments LP ($3.52M), CHI Advisors LLC ($3.07M), Dumac Inc. ($1.80M), and Silverarc Capital Management LLC ($880K).Learn more on SGMT's institutional investors. What percentage of Sagimet Biosciences stock is owned by institutional investors? 87.86% of Sagimet Biosciences stock is owned by institutional investors. Learn more on SGMT's institutional investor holdings. Which institutional investors have been buying Sagimet Biosciences stock? Of the 15 institutional investors that purchased Sagimet Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($2.67M), Vanguard Group Inc. ($894.32K), Rock Springs Capital Management LP ($738.36K), RTW Investments LP ($400.28K), Platinum Investment Management Ltd. ($383.91K), CHI Advisors LLC ($348.84K), and Dumac Inc. ($204.12K). How much institutional buying is happening at Sagimet Biosciences? Institutional investors have bought a total of 5,984,272 shares in the last 24 months. This purchase volume represents approximately $49.25M in transactions. Which Sagimet Biosciences major shareholders have been selling company stock? The following institutional investors have sold Sagimet Biosciences stock in the last 24 months: Platinum Investment Management Ltd. ($293.28K). How much institutional selling is happening at Sagimet Biosciences? Institutional investors have sold a total of 293,280 shares in the last 24 months. This volume of shares sold represents approximately $1.59M in transactions. Related Companies: I-Mab Institutional Ownership Regulus Therapeutics Institutional Ownership CervoMed Institutional Ownership InterCure Institutional Ownership PDS Biotechnology Institutional Ownership CytomX Therapeutics Institutional Ownership Repare Therapeutics Institutional Ownership Seres Therapeutics Institutional Ownership Adicet Bio Institutional Ownership Syros Pharmaceuticals Institutional Ownership This page (NASDAQ:SGMT) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
